{"id":"4p004","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Further research is needed to understand the exact mechanism of action of 4P004.","oneSentence":"4P004 is a small molecule that targets the [unknown molecular target] to treat [unknown therapeutic area].","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T02:26:36.690Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07225829","phase":"PHASE2","title":"A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis","status":"RECRUITING","sponsor":"4Moving Biotech","startDate":"2025-06-17","conditions":"Knee Osteoarthritis, Synovitis of Knee","enrollment":129},{"nctId":"NCT05419856","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee","status":"COMPLETED","sponsor":"4Moving Biotech","startDate":"2022-08-09","conditions":"Knee Osteoarthritis","enrollment":34}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Liraglutide"],"phase":"phase_2","status":"active","brandName":"4P004","genericName":"4P004","companyName":"4Moving Biotech","companyId":"4moving-biotech","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}